ARCHIVES

Banned Investigator Plans To Resume Clinical Trials Role

This article is from The Cancer Letter archive.

Vol. 16 No. 32 | August 10, 1990

Download PDF Visit The Full Archive

Related Articles

Sentinel Node Disection No Worse Than Axillary

February 25, 2011

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

May 9, 2003

NCI Treatment Division To Recompete $10 Million In Resource Contracts; Board Okays New Projects

November 12, 1976

ICCCR Issues RFP For Cancer Risk Scale

March 6, 1992

FDA Reaction to DCT Proposals ‘Positive,’ But Chabner, Wittes ‘Disappointed’ In That Response

June 17, 1988

Phase III PANORAMA-1 Trial Meets PFS Primary Endpoint

June 27, 2014